Effects of benzoquinolizine homologues on proliferative and exudative inflammation.
D000311:Adrenal Glands / Q000502:physiology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001835:Body Weight; D002351:Carrageenan; D002395:Catecholamines / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004487:Edema / Q000139:chemically induced; D005122:Exudates and Transudates / Q000187:drug effects*; D005508:Food Deprivation; D006854:Hydrocortisone / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy*; D008297:Male; D009929:Organ Size; D010634:Phenobarbital / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D011807:Quinolizines / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013747:Tetrabenazine / Q000494:pharmacology; D014868:Water Deprivation
D000893:Anti-Inflammatory Agents; D002395:Catecholamines; D011807:Quinolizines; D012110:Reserpine; D002351:Carrageenan; D010653:Phenylbutazone; D002746:Chlorpromazine; D006854:Hydrocortisone; D007213:Indomethacin; D010634:Phenobarbital; D013747:Tetrabenazine